Amyloid processing refers to the enzymatic cleavage of amyloid precursor protein (APP) into peptides, including beta-amyloid. This natural cellular mechanism is central to Alzheimer’s disease research, as abnormal accumulation of these fragments forms toxic plaques. Scientists study it to develop therapies that reduce plaque buildup, benefiting patients, caregivers, and pharmaceutical researchers seeking early intervention strategies.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends